CHRACCRISPRプラスミド
サンタクルスバイオテクノロジー社は遺伝子サイレンシング用のCRISPR/Cas9ノックアウト及びCRISPR Double Nickaseプラスミドを含め、広範囲の遺伝子編集製品を提供しております。CHRAC遺伝子サイレンサーは、CHRAC CRISPR/Cas9ノックアウトプラスミドとCHRACDouble Nickaseプラスミドとして利用可能です。遺伝子活性化用のCHRACCRISPR/dCas9 Activationプラスミド及びCRISPR Lenti Activationシステムも利用できます。遺伝子サイレンサーと活性化剤はタンパク質の検出に使用された抗体と組み合わせた遺伝子研究に有用です。
CHRAC CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
CHRAC15 CRISPR/Cas9 KOプラスミド (h) | sc-412266 | h | Gene Knockout | GFP | 0 | ||
CHRAC15 HDRプラスミド (h) | sc-412266-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
CHRAC15 Double Nickaseプラスミド (h) | sc-412266-NIC | h | Gene Knockout | Puromycin | 0 | ||
CHRAC15 Double Nickaseプラスミド (h2) | sc-412266-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
CHRAC15 CRISPR/Cas9 KOプラスミド (m) | sc-430006 | m | Gene Knockout | GFP | 0 | ||
CHRAC15 HDRプラスミド (m) | sc-430006-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
CHRAC15 Double Nickaseプラスミド (m) | sc-430006-NIC | m | Gene Knockout | Puromycin | 0 | ||
CHRAC15 Double Nickaseプラスミド (m2) | sc-430006-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
CHRAC17 CRISPR/Cas9 KOプラスミド (h) | sc-407797 | h | Gene Knockout | GFP | 0 | ||
CHRAC17 HDRプラスミド (h) | sc-407797-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
CHRAC17 Double Nickaseプラスミド (h) | sc-407797-NIC | h | Gene Knockout | Puromycin | 0 | ||
CHRAC17 Double Nickaseプラスミド (h2) | sc-407797-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
CHRAC17 CRISPR/Cas9 KOプラスミド (m) | sc-425547 | m | Gene Knockout | GFP | 0 | ||
CHRAC17 HDRプラスミド (m) | sc-425547-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
CHRAC17 Double Nickaseプラスミド (m) | sc-425547-NIC | m | Gene Knockout | Puromycin | 0 | ||
CHRAC17 Double Nickaseプラスミド (m2) | sc-425547-NIC-2 | m | Gene Knockout | Puromycin | 0 |
CHRAC CRISPR Activation Products
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
CHRAC15 CRISPR Activationプラスミド (h) | sc-412266-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CHRAC15 CRISPR Activationプラスミド (h2) | sc-412266-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CHRAC15 Lentiviral Activation Particles (h) | sc-412266-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CHRAC15 Lentiviral Activation Particles (h2) | sc-412266-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CHRAC15 CRISPR Activationプラスミド (m) | sc-430006-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
CHRAC15 CRISPR Activationプラスミド (m2) | sc-430006-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
CHRAC15 Lentiviral Activation Particles (m) | sc-430006-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
CHRAC15 Lentiviral Activation Particles (m2) | sc-430006-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
CHRAC17 CRISPR Activationプラスミド (h) | sc-407797-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CHRAC17 CRISPR Activationプラスミド (h2) | sc-407797-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CHRAC17 Lentiviral Activation Particles (h) | sc-407797-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CHRAC17 Lentiviral Activation Particles (h2) | sc-407797-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CHRAC17 CRISPR Activationプラスミド (m) | sc-425547-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
CHRAC17 CRISPR Activationプラスミド (m2) | sc-425547-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
CHRAC17 Lentiviral Activation Particles (m) | sc-425547-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
CHRAC17 Lentiviral Activation Particles (m2) | sc-425547-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |